Search - tctmd.com

Displaying 121 - 133 of 133

Sort: Relevancy | Date

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

November 27, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Daily News

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

L.A. McKeown

May 06, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Industry News

Advertisement

Oral Sirolimus Appears to Augment Efficacy of BMS

Paclitaxel Delivery Key to PAD Intervention

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

First DES for Above-the-Knee Vascular Disease on the Horizon

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content